Tuning the specificity of a Two-in-One Fab against three angiogenic antigens by fully utilizing the information of deep mutational scanning

References

• Eisen HN, Chakraborty AK. Evolving concepts of specificity in immune reactions. Proc Natl Acad Sci 2010; 107:22373-80; PMID:21173256; https://doi.org/10.1073/pnas.1012051108
   PubMed Web of Science ®Google Scholar
• Michaelides MC, Eisen HN. The strange cross-reaction of menadione (vitamin K3) and 2,4-dinitrophenyl ligands with a myeloma protein and some conventional antibodies. J Exp Med 1974; 140:687-702; PMID:4138007; https://doi.org/10.1084/jem.140.3.687
   PubMed Web of Science ®Google Scholar
• Lee CV, Hymowitz SG, Wallweber HJ, Gordon NC, Billeci KL, Tsai S-P, Compaan DM, Yin J, Gong Q, Kelley RF, et al. Synthetic anti-BR3 antibodies that mimic BAFF binding and target both human and murine B cells. Blood 2006; 108:3103-11; PMID:16840730; https://doi.org/10.1182/blood-2006-03-011031
   PubMed Web of Science ®Google Scholar
• Fuh G, Wu P, Liang W-C, Ultsch M, Lee CV, Moffat B, Wiesmann C. Structure-function studies of two synthetic anti-vascular endothelial growth factor fabs and comparison with the avastin™ Fab. J Biol Chem 2006; 281:6625-31; PMID:16373345; https://doi.org/10.1074/jbc.M507783200
   PubMed Web of Science ®Google Scholar
• Hamdani N, van der Velden J. Lack of specificity of antibodies directed against human beta-adrenergic receptors. Naunyn Schmiedebergs Arch Pharmacol 2009; 379:403-7; PMID:19156400; https://doi.org/10.1007/s00210-009-0392-1
   PubMed Web of Science ®Google Scholar
• Pradidarcheep W, Stallen J, Labruyère WT, Dabhoiwala NF, Michel MC, Lamers WH. Lack of specificity of commercially available antisera against muscarinergic and adrenergic receptors. Naunyn Schmiedebergs Arch Pharmacol 2009; 379:397-402; PMID:19198807; https://doi.org/10.1007/s00210-009-0393-0
   PubMed Web of Science ®Google Scholar
• Sanders BM, Martin LS, Nakagawa PA, Hunter DA, Miller S, Ullrich SJ. Specific cross-reactivity of antibodies raised against two major stress proteins, stress 70 and chaperonin 60, in diverse species. Environ Toxicol Chem 1994; 13:1241-9; https://doi.org/10.1002/etc.5620130805
   Web of Science ®Google Scholar
• James LC, Roversi P, Tawfik DS. Antibody multispecificity mediated by conformational diversity. Science 2003; 299:1362-7; PMID:12610298; https://doi.org/10.1126/science.1079731
   PubMed Web of Science ®Google Scholar
• Farady CJ, Sellers BD, Jacobson MP, Craik CS. Improving the species cross-reactivity of an antibody using computational design. Bioorg Med Chem Lett 2009; 19:3744-7; PMID:19477127; https://doi.org/10.1016/j.bmcl.2009.05.005
   PubMed Web of Science ®Google Scholar
• Riaño-Umbarila L, Contreras-Ferrat G, Olamendi-Portugal T, Morelos-Juárez C, Corzo G, Possani LD, Becerril B. Exploiting cross-reactivity to neutralize two different scorpion venoms with one single chain antibody fragment. J Biol Chem 2011; 286:6143-51; PMID:21156801; https://doi.org/10.1074/jbc.M110.189175
   PubMed Web of Science ®Google Scholar
• Garcia-Rodriguez C, Levy R, Arndt JW, Forsyth CM, Razai A, Lou J, Geren I, Stevens RC, Marks JD. Molecular evolution of antibody cross-reactivity for two subtypes of type A botulinum neurotoxin. Nat Biotechnol 2007; 25:107-16; PMID:17173035; https://doi.org/10.1038/nbt1269
   PubMed Web of Science ®Google Scholar
• Miyazaki C, Iba Y, Yamada Y, Takahashi H, Sawada J, Kurosawa Y. Changes in the specificity of antibodies by site-specific mutagenesis followed by random mutagenesis. Protein Eng 1999; 12:407-15; PMID:10360981; https://doi.org/10.1093/protein/12.5.407
   PubMedGoogle Scholar
• Korpimäki T, Rosenberg J, Virtanen P, Lamminmäki U, Tuomola M, Saviranta P. Further improvement of broad specificity hapten recognition with protein engineering. Protein Eng 2003; 16:37-46; PMID:12646691; https://doi.org/10.1093/proeng/gzg010
   PubMedGoogle Scholar
• Fagète S, Ravn U, Gueneau F, Magistrelli G, Kosco-Vilbois MH, Fischer N. Specificity tuning of antibody fragments to neutralize two human chemokines with a single agent. mAbs 2009; 1:288-96; PMID:20069756; https://doi.org/10.4161/mabs.1.3.8527
   PubMed Web of Science ®Google Scholar
• Yin Y, Djakovic S, Marsters S, Tien J, Peng J, Tremayne J, Lee G, Neve RM, Wu Y, Merchant M, et al. Redesigning a monospecific anti-FGFR3 antibody to add selectivity for FGFR2 and expand antitumor activity. Mol Cancer Ther 2015; 14:2270-8; PMID:26269606; https://doi.org/10.1158/1535-7163.MCT-14-1050
   PubMed Web of Science ®Google Scholar
• Dubreuil O, Bossus M, Graille M, Bilous M, Savatier A, Jolivet M, Ménez A, Stura E, Ducancel F. Fine tuning of the specificity of an anti-progesterone antibody by first and second sphere residue engineering. J Biol Chem 2005; 280:24880-7; PMID:15878862; https://doi.org/10.1074/jbc.M500048200
   PubMed Web of Science ®Google Scholar
• Chames P, Coulon S, Baty D. Improving the affinity and the fine specificity of an anti-cortisol antibody by parsimonious mutagenesis and phage display. J Immunol 1998; 161:5421-9; PMID:9820517
   PubMed Web of Science ®Google Scholar
• Lamminmäki U, Westerlund-Karlsson A, Toivola M, Saviranta P. Modulating the binding properties of an anti-17β-estradiol antibody by systematic mutation combinations. Protein Sci Publ Protein Soc 2003; 12:2549-58; PMID:14573866; https://doi.org/10.1110/ps.0353903
   PubMed Web of Science ®Google Scholar
• Bumbaca D, Wong A, Drake E, Reyes AE, Lin BC, Stephan J-P, Desnoyers L, Shen B-Q, Dennis MS. Highly specific off-target binding identified and eliminated during the humanization of an antibody against FGF receptor 4. mAbs 2011; 3:376-86; PMID:21540647; https://doi.org/10.4161/mabs.3.4.15786
   PubMed Web of Science ®Google Scholar
• Bostrom J, Yu S-F, Kan D, Appleton BA, Lee CV, Billeci K, Man W, Peale F, Ross S, Wiesmann C, et al. Variants of the antibody herceptin that interact with HER2 and VEGF at the antigen binding site. Science 2009; 323:1610-4; PMID:19299620; https://doi.org/10.1126/science.1165480
   PubMed Web of Science ®Google Scholar
• Schaefer G, Haber L, Crocker LM, Shia S, Shao L, Dowbenko D, Totpal K, Wong A, Lee CV, Stawicki S, et al. A Two-in-One antibody against HER3 and EGFR Has superior inhibitory activity compared with monospecific antibodies. Cancer Cell 2011; 20:472-86; PMID:22014573; https://doi.org/10.1016/j.ccr.2011.09.003
   PubMed Web of Science ®Google Scholar
• Lee CV, Koenig P, Fuh G. A Two-in-One antibody engineered from a humanized interleukin 4 antibody through mutation in heavy chain complementarity-determining regions. mAbs 2014; 6:622-7; PMID:24618680; https://doi.org/10.4161/mabs.28483
   PubMed Web of Science ®Google Scholar
• Fowler DM, Araya CL, Fleishman SJ, Kellogg EH, Stephany JJ, Baker D, Fields S. High resolution mapping of protein sequence–function relationships. Nat Methods 2010; 7:741-6; PMID:20711194; https://doi.org/10.1038/nmeth.1492
   PubMed Web of Science ®Google Scholar
• Whitehead TA, Chevalier A, Song Y, Dreyfus C, Fleishman SJ, De Mattos C, Myers CA, Kamisetty H, Blair P, Wilson IA, et al. Optimization of affinity, specificity and function of designed influenza inhibitors using deep sequencing. Nat Biotechnol 2012; 30:543-8; PMID:22634563; https://doi.org/10.1038/nbt.2214
   PubMed Web of Science ®Google Scholar
• Forsyth CM, Juan V, Akamatsu Y, DuBridge RB, Doan M, Ivanov AV, Ma Z, Polakoff D, Razo J, Wilson K, et al. Deep mutational scanning of an antibody against epidermal growth factor receptor using mammalian cell display and massively parallel pyrosequencing. mAbs 2013; 5:523-32; PMID:23765106; https://doi.org/10.4161/mabs.24979
   PubMed Web of Science ®Google Scholar
• Fujino Y, Fujita R, Wada K, Fujishige K, Kanamori T, Hunt L, Shimizu Y, Ueda T. Robust in vitro affinity maturation strategy based on interface-focused high-throughput mutational scanning. Biochem Biophys Res Commun 2012; 428:395-400; PMID:23103372; https://doi.org/10.1016/j.bbrc.2012.10.066
   PubMed Web of Science ®Google Scholar
• Koenig P, Lee CV, Walters BT, Janakiraman V, Stinson J, Patapoff TW, Fuh G. Mutational landscape of antibody variable domains reveals a switch modulating the interdomain conformational dynamics and antigen binding. Proc Natl Acad Sci 2017; 114(4):E486-95: 201613231; PMID:28057863; https://doi.org/10.1073/pnas.1613231114
   PubMed Web of Science ®Google Scholar
• Koenig P, Lee CV, Sanowar S, Wu P, Stinson J, Harris SF, Fuh G. Deep Sequencing-guided design of a high affinity dual specificity antibody to target two angiogenic factors in neovascular age-related macular degeneration. J Biol Chem 2015; 290:21773-86; PMID:26088137; https://doi.org/10.1074/jbc.M115.662783
   PubMed Web of Science ®Google Scholar
• Fagiani E, Christofori G. Angiopoietins in angiogenesis. Cancer Lett 2013; 328:18-26; PMID:22922303; https://doi.org/10.1016/j.canlet.2012.08.018
   PubMed Web of Science ®Google Scholar
• van Lookeren Campagne M, LeCouter J, Yaspan BL, Ye W. Mechanisms of age-related macular degeneration and therapeutic opportunities: Pathology, genetics, animal models, and therapeutic rationale of AMD. J Pathol 2014; 232:151-64; PMID:24105633; https://doi.org/10.1002/path.4266
   PubMed Web of Science ®Google Scholar
• Thomson BR, Heinen S, Jeansson M, Ghosh AK, Fatima A, Sung H-K, Onay T, Chen H, Yamaguchi S, Economides AN, et al. A lymphatic defect causes ocular hypertension and glaucoma in mice. J Clin Invest 2014; 124:4320-4; PMID:25202984; https://doi.org/10.1172/JCI77162
   PubMed Web of Science ®Google Scholar
• Lowman HB, Bass SH, Simpson N, Wells JA. Selecting high-affinity binding proteins by monovalent phage display. Biochemistry (Mosc) 1991; 30:10832-8; PMID:1932005; https://doi.org/10.1021/bi00109a004
   PubMed Web of Science ®Google Scholar
• Jain T, Sun T, Durand S, Hall A, Houston NR, Nett JH, Sharkey B, Bobrowicz B, Caffry I, Yu Y, et al. Biophysical properties of the clinical-stage antibody landscape. Proc Natl Acad Sci 2017; 114:944-9; PMID:28096333; https://doi.org/10.1073/pnas.1616408114
   PubMed Web of Science ®Google Scholar
• Wang F, Sen S, Zhang Y, Ahmad I, Zhu X, Wilson IA, Smider VV, Magliery TJ, Schultz PG. Somatic hypermutation maintains antibody thermodynamic stability during affinity maturation. Proc Natl Acad Sci 2013; 110:4261-6; PMID:23440204; https://doi.org/10.1073/pnas.1301810110
   PubMed Web of Science ®Google Scholar
• Hotzel I, Theil FP, Bernstein LJ, Prabhu S, Deng R, Quintana L, Lutman J, Sibia R, Chan P, Bumbaca D. A strategy for risk mitigation of antibodies with fast clearance. mAbs 2012; 4:8-7; PMID:23778268; https://doi.org/10.4161/mabs.22189
   PubMed Web of Science ®Google Scholar
• Li B, Fouts AE, Stengel K, Luan P, Dillon M, Liang W-C, Feierbach B, Kelley RF, Hötzel I. In vitro affinity maturation of a natural human antibody overcomes a barrier to in vivo affinity maturation. mAbs 2014; 6:437-45; PMID:24492299; https://doi.org/10.4161/mabs.27875
   PubMed Web of Science ®Google Scholar
• Rajpal A, Beyaz N, Haber L, Cappuccilli G, Yee H, Bhatt RR, Takeuchi T, Lerner RA, Crea R. A general method for greatly improving the affinity of antibodies by using combinatorial libraries. Proc Natl Acad Sci U S A 2005; 102:8466-71; PMID:15939870; https://doi.org/10.1073/pnas.0503543102
   PubMed Web of Science ®Google Scholar
• Yang W-P, Green K, Pinz-Sweeney S, Briones AT, Burton DR, Barbas CF III. CDR walking mutagenesis for the affinity maturation of a potent human anti-HIV-1 antibody into the picomolar range. J Mol Biol 1995; 254:392-403; PMID:7490758; https://doi.org/10.1006/jmbi.1995.0626
   PubMed Web of Science ®Google Scholar
• Bostrom J, Lee CV, Haber L, Fuh G. Improving antibody binding affinity and specificity for therapeutic development [Internet]. In: Dimitrov AS, (Ed.), Therapeutic antibodies. Totowa, NJ: Humana Press; 2009, p 353-76
   Google Scholar
• Koenig P, Fuh G. Selection and screening using antibody phage display libraries. In: Ossipow V, Fischer N, (Eds.), Monoclonal antibodies. Totowa, NJ: Humana Press; 2014 page 133-49
   Google Scholar
• R Development Core Team. R: A language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing; 2008. Available from: http://www.R-project.org.
   Google Scholar
• Morgan M, Anders S, Lawrence M, Aboyoun P, Pagès H, Gentleman R. ShortRead: A bioconductor package for input, quality assessment and exploration of high-throughput sequence data. Bioinformatics 2009; 25:2607-8; PMID:19654119; https://doi.org/10.1093/bioinformatics/btp450
   PubMed Web of Science ®Google Scholar
• Wickham H. ggplot2: elegant graphics for data analysis. New York: Springer; 2009.
   Google Scholar
• Lee CV, Liang W-C, Dennis MS, Eigenbrot C, Sidhu SS, Fuh G. High-affinity human antibodies from phage-displayed synthetic Fab libraries with a single framework scaffold. J Mol Biol 2004; 340:1073-93; PMID:15236968; https://doi.org/10.1016/j.jmb.2004.05.051
   PubMed Web of Science ®Google Scholar
• Niesen FH, Berglund H, Vedadi M. The use of differential scanning fluorimetry to detect ligand interactions that promote protein stability. Nat Protoc 2007; 2:2212-21; PMID:17853878; https://doi.org/10.1038/nprot.2007.321
   PubMed Web of Science ®Google Scholar
• Yu X, Seegar TCM, Dalton AC, Tzvetkova-Robev D, Goldgur Y, Rajashankar KR, Nikolov DB, Barton WA. Structural basis for angiopoietin-1–mediated signaling initiation. Proc Natl Acad Sci 2013; 110:7205-10; PMID:23592718; https://doi.org/10.1073/pnas.1216890110
   PubMed Web of Science ®Google Scholar
• Collaborative Computational Project N 4. The CCP4 suite: programs for protein crystallography. Acta Crystallogr D Biol Crystallogr 1994; 50:760-3; PMID:15299374; https://doi.org/10.1107/S0907444994003112
   PubMedGoogle Scholar